Healthcare
Live Price
Offline$2.10
+6.06% today
1Y Change
-63.20%
Window
Jun 20, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 20, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Serina Therapeutics, Inc. (SER) is a Healthcare stock with a market cap of $20.00M and listed on AMEX. The stock last traded around $2.10 and down 63.2% across the available one-year price window (Jun 20, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +132.1%, EPS growth of -26.5%, a dividend yield of 0.0%. What stands out right now is revenue +132.1%, EPS -26.5%, free cash flow -4.6% with operating margin -18478.5% and ROIC -709.0%. Valuation already assumes a fairly strong business story at price/sales 139.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SER price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SER
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SER Max Drawdown
-79.25%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SER and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.